Xenon Pharmaceuticals (XENE) Misses Q1 EPS by 5c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.43), $0.05 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $300 thousand.

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Scorpio Tankers to redeem $200M notes, secures $90M credit facility
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance